Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-13 Option Award | 2024-02-14 6:44 pm | N/A 2034-02-12 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO AND PRESIDENT | 373,649 | $0 | 653,612 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 6:42 pm | N/A 2034-02-11 | TriSalus Life Sciences Inc. | TLSI | Marshak Richard SR.VP, CORP. DEV. & STRATEGY | 78,502 | $0 | 91,001 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 6:39 pm | N/A 2034-02-11 | TriSalus Life Sciences Inc. | TLSI | Cox Bryan F. CHIEF SCIENTIFIC & MANUFACT. | 78,502 | $0 | 150,446 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 6:36 pm | N/A 2034-02-11 | TriSalus Life Sciences Inc. | TLSI | Stevens Jennifer CHIEF REGULATORY OFFICER | 78,502 | $0 | 96,533 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 6:19 pm | N/A 2034-02-11 | TriSalus Life Sciences Inc. | TLSI | Devlin Jodi PRESIDENT, COMMERC. OPERATIONS | 122,500 | $0 | 122,500 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 6:17 pm | N/A 2034-02-11 | TriSalus Life Sciences Inc. | TLSI | Murphy Sean CHIEF FINANCIAL OFFICER | 139,144 | $0 | 681,055 (Direct) | View |
2024-02-12 Option Award | 2024-02-14 6:13 pm | N/A 2034-02-11 | TriSalus Life Sciences Inc. | TLSI | Katz Steven C CHIEF MEDICAL OFFICER | 139,144 | $0 | 173,587 (Direct) | View |
2024-01-24 Option Award | 2024-01-25 5:46 pm | N/A 2034-01-23 | TriSalus Life Sciences Inc. | TLSI | Murphy Sean CHIEF FINANCIAL OFFICER | 125,000 | $0 | 125,000 (Direct) | View |
2024-01-24 Option Award | 2024-01-25 5:43 pm | N/A 2034-01-23 | TriSalus Life Sciences Inc. | TLSI | Marshak Richard SR.VP, CORP. DEV. & STRATEGY | 40,000 | $0 | 40,000 (Direct) | View |
2023-08-30 Option Award | 2023-08-31 9:04 pm | N/A 2033-08-29 | TriSalus Life Sciences Inc. | TLSI | Devlin Jodi President, Therapeutics | 195,000 | $0 | 195,000 (Direct) | View |
2023-08-14 Option Award | 2023-08-15 4:48 pm | N/A 2033-08-13 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 172,500 | $0 | 172,500 (Direct) | View |
Ownership | 2023-08-15 4:46 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 0 | $0 | 906,895 (Direct) | View |
2023-08-11 Option Award | 2023-08-14 7:30 pm | N/A 2033-08-10 | TriSalus Life Sciences Inc. | TLSI | Stevens Jennifer Chief Regulatory Officer | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-08-14 7:22 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Stevens Jennifer Chief Regulatory Officer | 0 | $0 | 74,313 (Direct) | View |
2023-08-11 Option Award | 2023-08-14 7:21 pm | N/A 2033-08-10 | TriSalus Life Sciences Inc. | TLSI | Murphy Sean Chief Financial Officer | 62,500 | $0 | 62,500 (Direct) | View |
Ownership | 2023-08-14 7:19 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Murphy Sean Chief Financial Officer | 0 | $0 | 714,092 (Indirect) | View |
2023-08-11 Option Award | 2023-08-14 7:18 pm | N/A 2033-08-10 | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Sr.VP, Corp. Dev. & Strategy | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-08-14 7:16 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Sr.VP, Corp. Dev. & Strategy | 0 | $0 | 82,686 (Direct) | View |
2023-08-11 Option Award | 2023-08-14 7:14 pm | N/A 2033-08-10 | TriSalus Life Sciences Inc. | TLSI | Katz Steven C Chief Medical Officer | 62,500 | $0 | 62,500 (Direct) | View |
Ownership | 2023-08-14 7:12 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Katz Steven C Chief Medical Officer | 0 | $0 | 312,070 (Direct) | View |
2023-08-11 Option Award | 2023-08-14 7:10 pm | N/A 2033-08-10 | TriSalus Life Sciences Inc. | TLSI | Cox Bryan F. Chief Scientific & Manufact. | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-08-14 7:05 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Cox Bryan F. Chief Scientific & Manufact. | 0 | $0 | 86,398 (Direct) | View |
Ownership | 2023-08-14 7:02 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Alecxih James President, Device Technology | 0 | $0 | 189,508 (Direct) | View |
Ownership | 2023-08-14 6:23 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Frankenius Equity AB 10% Owner | 0 | $0 | 6,397,776 (Direct) | View |
2023-08-10 Option Award | 2023-08-14 6:19 pm | N/A 2033-08-09 | TriSalus Life Sciences Inc. | TLSI | Wahlstrom Mats Director 10% Owner | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2023-08-14 6:13 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Wahlstrom Mats Director 10% Owner | 0 | $0 | 2,810,232 (Indirect) | View |
2023-08-10 Option Award | 2023-08-14 6:10 pm | N/A 2033-08-09 | TriSalus Life Sciences Inc. | TLSI | VON ESCHENBACH ANDREW C. Director | 35,000 | $0 | 35,000 (Direct) | View |
2023-08-10 Option Award | 2023-08-14 6:03 pm | N/A 2033-08-09 | TriSalus Life Sciences Inc. | TLSI | Singhal Anil K. Director | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2023-08-14 6:00 pm | N/A 2028-07-23 | TriSalus Life Sciences Inc. | TLSI | Singhal Anil K. Director | 0 | $0 | 19,278 (Direct) | View |
2023-08-10 Other | 2023-08-14 5:58 pm | 2023-09-09 N/A | TriSalus Life Sciences Inc. | TLSI | MATLIN DAVID J Director | 2,172,422 | $0 | 3,239,326 (Direct) | View |
2023-08-10 Option Award | 2023-08-14 5:58 pm | N/A 2023-08-08 | TriSalus Life Sciences Inc. | TLSI | MATLIN DAVID J Director | 35,000 | $0 | 3,239,326 (Direct) | View |
2023-08-10 Option Award | 2023-08-14 5:58 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | MATLIN DAVID J Director | 100,000 | $10 | 3,239,326 (Direct) | View |
2023-08-10 Option Award | 2023-08-14 5:54 pm | N/A 2033-08-09 | TriSalus Life Sciences Inc. | TLSI | Martin George Kelly Director | 35,000 | $0 | 35,000 (Direct) | View |
2023-08-10 Option Award | 2023-08-14 5:47 pm | N/A 2033-08-09 | TriSalus Life Sciences Inc. | TLSI | HICKS KERRY R Director | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2023-08-14 5:42 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | HICKS KERRY R Director | 0 | $0 | 2,313,421 (Indirect) | View |
2023-08-10 Option Award | 2023-08-14 5:41 pm | N/A 2033-08-09 | TriSalus Life Sciences Inc. | TLSI | Desai Arjun JJ Director | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2023-08-14 5:37 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Desai Arjun JJ Director | 0 | $0 | 449,794 (Direct) | View |
2023-06-26 Conversion | 2023-06-27 4:13 pm | N/A N/A | MedTech Acquisition Corp | MTAC | MedTech Acquisition Sponsor LLC Dewey Christopher C MATLIN DAVID J 10% Owner | 6,249,999 | $0 | 6,250,000 (Direct) | View |
2023-06-12 Other | 2023-06-14 8:05 pm | N/A N/A | MedTech Acquisition Corp | MTAC | Magnetar Financial LLC Magnetar Capital Partners LP Supernova Management LLC Snyderman David J. 10% Owner | 445,828 | $10.49 | 985,210 (Indirect) | View |